📊 Community Poll: Oxidative Therapies & ROS in Cancer
Many conventional and metabolic cancer approaches rely—directly or indirectly—on oxidative stress (ROS: reactive oxygen species) to damage cancer cells. Chemotherapy, for example, is largely pro-oxidant and works by generating oxidative damage indiscriminately to both cancer cells and healthy cells. According to published work and commentary by Dr. Seyfried, chemotherapy may retain significant therapeutic effect at reduced doses when patients are in nutritional ketosis, potentially lowering collateral damage while maintaining efficacy. Beyond chemotherapy, many people explore targeted or context-dependent oxidative strategies, including: • Natural pro-oxidants (e.g. Artemisinin) • Repurposed / off-label agents (e.g. Fenbendazole, Doxycycline, Atorvastatin) • Oxygen-based therapies (e.g. HBOT, ozone, IV vitamin C) • Redox-active approaches (e.g. Methylene Blue + Light (Red / NIR) • Direct Systemic Oxidants (e.g. CDS, Hydrogen Peroxide) • Redox-Active Solvent / Carrier (e.g. DMSO) This poll aims to better understand how frequently these approaches are being used or considered, and to gather insight into real-world use and observed outcomes within the community. Which best describes you?